Antibiotic Makers Struggle, Hurting War on Superbugs

  06 January 2020

The world desperately needs new antibiotics to tackle the rising threat of drug-resistant superbugs, but there is little reward for doing so.

Instead, the companies that have stepped up to the challenge are going bust.

Makers of newly approved antibiotic drugs are struggling to generate sales because doctors prescribe the treatments sparingly….

Further reading: The Wall Street Journal
Author(s): Denise Roland
Smart Innovations  
Back


Registration now open:

International Masterclass AMR 29 SEP delivered digitally: 2 = 1!

 

  • Science, Health-Economic & Societal impact
  • Global causes and global solutions
  • Bottom-up, interactive approach
  • International Experts involved

Offered online!

Register today >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!